There's a Lot to Like in AbbVie's Q3 Update
AbbVie (NYSE: ABBV) has set a pattern in recent quarters of meeting or barely exceeding consensus analysts' earnings estimates. It's not that the big biotech hasn't performed well; rather, expectations have been pretty high for AbbVie.
That was the case once more for AbbVie entering the third quarter. The company announced its earnings results before the market opened on Friday. AbbVie yet again turned in a strong performance. And it yet again narrowly topped earnings estimates. Here are the highlights.
Image source: Getty Images.
Source: Fool.com
AbbVie Inc. Aktie
174,48 €
0,65 %
Die AbbVie Inc. Aktie genießt uneingeschränkte Beliebtheit: Nur Buy-Einschätzungen.
Ein Kursziel von 180 € für AbbVie Inc. zeigt ein leicht positives Potenzial im Vergleich zum aktuellen Kurs von 174.48 €.
